|
PIAS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.21944684852815E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.37678798653951E-12 |
| Normal-vs-Stage2 |
2.16999751501135E-11 |
| Normal-vs-Stage3 |
7.8159700933611E-14 |
| Normal-vs-Stage4 |
6.42819131257966E-14 |
| Stage1-vs-Stage2 |
2.572400E-01 |
| Stage1-vs-Stage3 |
5.252400E-02 |
| Stage1-vs-Stage4 |
3.134500E-02 |
| Stage2-vs-Stage3 |
7.970000E-01 |
| Stage2-vs-Stage4 |
6.451000E-01 |
| Stage3-vs-Stage4 |
7.799400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.09132711148641E-12 |
| Normal-vs-AfricanAmerican |
1.75160000004393E-06 |
| Normal-vs-Asian |
6.29160057386002E-11 |
| Caucasian-vs-AfricanAmerican |
3.394800E-01 |
| Caucasian-vs-Asian |
5.362200E-01 |
| AfricanAmerican-vs-Asian |
6.508000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.74793512996985E-12 |
| Normal-vs-Female |
2.79243295153719E-12 |
| Male-vs-Female |
2.014000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.97175650543613E-12 |
| Normal-vs-Age(41-60Yrs) |
8.48432435418545E-13 |
| Normal-vs-Age(61-80Yrs) |
1.66178182325893E-12 |
| Normal-vs-Age(81-100Yrs) |
6.19389999999553E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.549000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.444400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.381400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.050000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.435200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.509600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.220500E-03 |
| Classical-VS-Follicular |
8.470100E-02 |
| Classical-VS-Other |
4.046000E-01 |
| Classical-VS-Normal |
1.61199942283474E-11 |
| Tall-VS-Follicular |
2.770200E-01 |
| Tall-VS-Other |
7.453200E-01 |
| Tall-VS-Normal |
1.67743596790615E-12 |
| Follicular-VS-Other |
8.166400E-01 |
| Follicular-VS-Normal |
2.43427500379312E-12 |
| Other-VS-Normal |
4.85429999996789E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.4535928844216E-13 |
| Normal-vs-N1 |
1.49810053251542E-10 |
| N0-vs-N1 |
9.499200E-01 |
|
|
